Oncotype DX RS

1 abstract

Abstract
Impact of HER2 low expression in the Oncotype DX RS in patients with operable hormone receptor positive early stage breast cancer.
Org: Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, New York Oncology Hematology PC, Weill Cornell Medicine/New York Presbyterian Hospital,